Ionis Pharmaceuticals IncNASDAQ:IONS
- LAST PRICE51.4500
- TODAY'S CHANGE (%)-0.4100 (-0.7906%)
- Bid / Lots51.4500/ 1
- Ask / Lots53.0000/ 1
- Open / Previous Close52.1800 / 51.8600
- Day Range
- 52 Week Range
- Volume766,354
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | IONS |
|---|---|---|
| 09:32 ET | 4465 | 52.11 |
| 09:34 ET | 2481 | 51.68 |
| 09:36 ET | 5322 | 51.77 |
| 09:38 ET | 700 | 51.9 |
| 09:39 ET | 1701 | 52.04 |
| 09:41 ET | 324 | 52.01 |
| 09:43 ET | 1600 | 51.89 |
| 09:45 ET | 4526 | 52.07 |
| 09:48 ET | 521 | 52.26 |
| 09:50 ET | 300 | 52.12 |
| 09:52 ET | 800 | 52.05 |
| 09:54 ET | 1441 | 51.96 |
| 09:56 ET | 3160 | 52.075 |
| 09:57 ET | 1789 | 52.095 |
| 09:59 ET | 1200 | 51.96 |
| 10:01 ET | 516 | 52.08 |
| 10:03 ET | 200 | 52 |
| 10:06 ET | 900 | 51.93 |
| 10:08 ET | 300 | 51.82 |
| 10:10 ET | 1071 | 51.805 |
| 10:12 ET | 901 | 51.94 |
| 10:14 ET | 300 | 51.955 |
| 10:15 ET | 1502 | 51.765 |
| 10:17 ET | 500 | 51.73 |
| 10:19 ET | 1490 | 51.69 |
| 10:21 ET | 1400 | 51.57 |
| 10:24 ET | 400 | 51.605 |
| 10:28 ET | 200 | 51.67 |
| 10:30 ET | 495 | 51.64 |
| 10:32 ET | 2630 | 51.65 |
| 10:33 ET | 1202 | 51.65 |
| 10:35 ET | 1665 | 51.64 |
| 10:37 ET | 260 | 51.63 |
| 10:39 ET | 1745 | 51.83 |
| 10:42 ET | 1994 | 51.87 |
| 10:44 ET | 500 | 51.84 |
| 10:46 ET | 839 | 51.665 |
| 10:48 ET | 200 | 51.64 |
| 10:50 ET | 600 | 51.58 |
| 10:51 ET | 1156 | 51.57 |
| 10:53 ET | 5500 | 51.44 |
| 10:55 ET | 1357 | 51.405 |
| 10:57 ET | 2754 | 51.44 |
| 11:00 ET | 800 | 51.46 |
| 11:04 ET | 3282 | 51.565 |
| 11:06 ET | 900 | 51.515 |
| 11:08 ET | 500 | 51.435 |
| 11:09 ET | 1000 | 51.51 |
| 11:11 ET | 688 | 51.49 |
| 11:13 ET | 300 | 51.44 |
| 11:15 ET | 999 | 51.435 |
| 11:18 ET | 407 | 51.37 |
| 11:20 ET | 700 | 51.34 |
| 11:22 ET | 1300 | 51.22 |
| 11:24 ET | 1739 | 51.25 |
| 11:26 ET | 1342 | 51.29 |
| 11:27 ET | 800 | 51.355 |
| 11:29 ET | 1600 | 51.33 |
| 11:31 ET | 1199 | 51.38 |
| 11:33 ET | 1592 | 51.345 |
| 11:36 ET | 1340 | 51.24 |
| 11:38 ET | 1000 | 51.25 |
| 11:40 ET | 2058 | 51.36 |
| 11:42 ET | 620 | 51.4 |
| 11:44 ET | 278 | 51.38 |
| 11:45 ET | 500 | 51.48 |
| 11:47 ET | 600 | 51.52 |
| 11:49 ET | 2200 | 51.445 |
| 11:51 ET | 600 | 51.43 |
| 11:54 ET | 1034 | 51.45 |
| 11:56 ET | 1827 | 51.41 |
| 11:58 ET | 500 | 51.31 |
| 12:00 ET | 600 | 51.34 |
| 12:02 ET | 1568 | 51.43 |
| 12:03 ET | 527 | 51.52 |
| 12:07 ET | 225 | 51.58 |
| 12:09 ET | 340 | 51.63 |
| 12:12 ET | 400 | 51.61 |
| 12:14 ET | 500 | 51.55 |
| 12:16 ET | 314 | 51.555 |
| 12:18 ET | 2000 | 51.62 |
| 12:20 ET | 587 | 51.52 |
| 12:21 ET | 3200 | 51.495 |
| 12:23 ET | 1067 | 51.39 |
| 12:25 ET | 400 | 51.385 |
| 12:27 ET | 248 | 51.3785 |
| 12:30 ET | 400 | 51.355 |
| 12:34 ET | 741 | 51.4 |
| 12:36 ET | 100 | 51.33 |
| 12:38 ET | 800 | 51.357 |
| 12:39 ET | 408 | 51.44 |
| 12:41 ET | 100 | 51.39 |
| 12:43 ET | 1600 | 51.415 |
| 12:45 ET | 300 | 51.36 |
| 12:48 ET | 600 | 51.43 |
| 12:50 ET | 300 | 51.43 |
| 12:52 ET | 100 | 51.42 |
| 12:56 ET | 700 | 51.37 |
| 12:57 ET | 112 | 51.35 |
| 12:59 ET | 327 | 51.39 |
| 01:01 ET | 400 | 51.34 |
| 01:03 ET | 1017 | 51.27 |
| 01:06 ET | 1011 | 51.37 |
| 01:08 ET | 600 | 51.26 |
| 01:10 ET | 300 | 51.235 |
| 01:12 ET | 337 | 51.21 |
| 01:14 ET | 327 | 51.18 |
| 01:15 ET | 761 | 51.215 |
| 01:17 ET | 200 | 51.18 |
| 01:19 ET | 400 | 51.18 |
| 01:21 ET | 100 | 51.15 |
| 01:24 ET | 600 | 51.1 |
| 01:26 ET | 1476 | 51.19 |
| 01:28 ET | 952 | 51.22 |
| 01:32 ET | 200 | 51.24 |
| 01:33 ET | 704 | 51.19 |
| 01:35 ET | 1633 | 51.05 |
| 01:37 ET | 1559 | 51.1 |
| 01:39 ET | 900 | 51.13 |
| 01:42 ET | 550 | 51.165 |
| 01:46 ET | 200 | 51.27 |
| 01:48 ET | 400 | 51.33 |
| 01:50 ET | 500 | 51.29 |
| 01:53 ET | 2303 | 51.21 |
| 01:55 ET | 100 | 51.205 |
| 01:57 ET | 100 | 51.18 |
| 02:00 ET | 100 | 51.2 |
| 02:02 ET | 480 | 51.2069 |
| 02:04 ET | 700 | 51.355 |
| 02:06 ET | 1013 | 51.27 |
| 02:08 ET | 640 | 51.27 |
| 02:09 ET | 100 | 51.28 |
| 02:13 ET | 100 | 51.335 |
| 02:15 ET | 100 | 51.33 |
| 02:18 ET | 845 | 51.36 |
| 02:20 ET | 800 | 51.4 |
| 02:22 ET | 1326 | 51.42 |
| 02:24 ET | 2298 | 51.46 |
| 02:26 ET | 100 | 51.55 |
| 02:27 ET | 1066 | 51.565 |
| 02:29 ET | 694 | 51.55 |
| 02:31 ET | 646 | 51.5 |
| 02:33 ET | 700 | 51.505 |
| 02:36 ET | 1400 | 51.63 |
| 02:38 ET | 1445 | 51.49 |
| 02:40 ET | 200 | 51.5 |
| 02:42 ET | 700 | 51.485 |
| 02:44 ET | 600 | 51.5 |
| 02:47 ET | 200 | 51.51 |
| 02:49 ET | 651 | 51.47 |
| 02:51 ET | 872 | 51.49 |
| 02:54 ET | 2463 | 51.45 |
| 02:56 ET | 700 | 51.43 |
| 02:58 ET | 1548 | 51.45 |
| 03:00 ET | 409 | 51.44 |
| 03:02 ET | 906 | 51.43 |
| 03:03 ET | 800 | 51.44 |
| 03:05 ET | 100 | 51.43 |
| 03:07 ET | 1000 | 51.43 |
| 03:09 ET | 702 | 51.475 |
| 03:12 ET | 361 | 51.51 |
| 03:14 ET | 700 | 51.53 |
| 03:16 ET | 1000 | 51.465 |
| 03:18 ET | 851 | 51.47 |
| 03:21 ET | 949 | 51.49 |
| 03:23 ET | 4471 | 51.515 |
| 03:25 ET | 955 | 51.565 |
| 03:27 ET | 300 | 51.56 |
| 03:30 ET | 2792 | 51.46 |
| 03:32 ET | 1400 | 51.475 |
| 03:34 ET | 1648 | 51.46 |
| 03:36 ET | 733 | 51.51 |
| 03:38 ET | 620 | 51.54 |
| 03:39 ET | 1401 | 51.56 |
| 03:41 ET | 1237 | 51.62 |
| 03:43 ET | 2278 | 51.63 |
| 03:45 ET | 2684 | 51.61 |
| 03:48 ET | 2733 | 51.55 |
| 03:50 ET | 2155 | 51.475 |
| 03:52 ET | 2728 | 51.62 |
| 03:54 ET | 3822 | 51.545 |
| 03:56 ET | 6177 | 51.51 |
| 03:57 ET | 8175 | 51.49 |
| 03:59 ET | 33511 | 51.45 |
Jul 24, 2024
DJ Ionis Pharmaceuticals Raised to Outperform From Market Perform by Leerink Partners, from 6:57AM ET on Wednesday Jul 24, 2024 by Dow Jones
6:57AM ET on Wednesday Jul 24, 2024 by Dow Jones
Jul 23, 2024
DJ Ionis Pharmaceuticals Is Maintained at Buy by TD Cowen, from 1:13PM ET on Tuesday Jul 23, 2024 by Dow Jones
1:13PM ET on Tuesday Jul 23, 2024 by Dow JonesDJ Ionis Pharmaceuticals Is Maintained at Buy by B of A Securities, from 9:50AM ET on Tuesday Jul 23, 2024 by Dow Jones
9:50AM ET on Tuesday Jul 23, 2024 by Dow Jones
Jul 22, 2024
DJ Ionis Pharmaceuticals Price Target Maintained With a $60.00/Share by Needham, from 2:45PM ET on Monday Jul 22, 2024 by Dow Jones
2:45PM ET on Monday Jul 22, 2024 by Dow JonesDJ Ionis Shares Rise 6% After Results Angelman Syndrome Treatment Data, from 1:50PM ET on Monday Jul 22, 2024 by Dow Jones
1:50PM ET on Monday Jul 22, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Ionis Pharmaceuticals Inc | 7.6B | -19.3x | --- |
Halozyme Therapeutics Inc | 7.1B | 23.3x | --- |
Tempus AI Inc | 6.6B | -23.6x | --- |
Intra-Cellular Therapies Inc | 8.5B | -69.8x | --- |
Blueprint Medicines Corp | 7.1B | -23.3x | --- |
Ascendis Pharma A/S | 7.8B | -13.9x | --- |
Company Information
Ionis Pharmaceuticals, Inc. is engaged in ribonucleic acid (RNA)-targeted therapeutics. The Company has five marketed medicines and a pipeline in neurology, cardiology, and other areas of high patient need. It has nine medicines in Phase III development and multiple additional medicines in early and mid-stage development. The Company’s products include SPINRAZA, QALSODY, WAINUA, TEGSEDI and WAYLIVRA. SPINRAZA is used for the treatment of patients with spinal muscular atrophy (SMA), a progressive, debilitating and often fatal genetic disease. QALSODY is an antisense medicine that is used for the treatment of adult patients with superoxide dismutase 1 amyotrophic lateral sclerosis (SOD1-ALS), a rare, neurodegenerative disorder that causes progressive loss of motor neurons leading to death. WAINUA is a self-administered subcutaneous LIgand-Conjugated Antisense (LICA) medicine used for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated amyloidosis (ATTRv-PN).
Contact Information
- Headquarters
- 2855 Gazelle CourtCARLSBAD, CA, United States 92010
- Phone
- 760-931-9200
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Joseph Loscalzo
- Chief Executive Officer, Director
- Brett Monia
- Chief Financial Officer, Executive Vice President - Finance
- Elizabeth Hougen
- Chief Scientific Officer
- C. Frank Bennett
- Executive Vice President, Chief Business Officer
- Joseph Baroldi
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $7.6B |
|---|---|
Revenue (TTM) | $776.6M |
Shares Outstanding | 146.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.38 |
EPS | $-2.67 |
Book Value | $2.68 |
P/E Ratio | -19.3x |
Price/Sales (TTM) | 9.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -48.38% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
